Phase II study of docetaxel, cisplatin and capecitabine as preoperative chemotherapy in resectable gastric cancer

Table 1 Patient characteristics at baseline

Characteristics	No. of patients	%
Age, yr
Median	64
Range	34-84
Age, category
< 50 yr	5	9.8
50-59 yr	8	15.7
60-69 yr	22	43.1
70-79 yr	15	29.4
> 80 yr	1	2
Sex
Male	36	70.6
Female	15	29.4
WHO performance status1
0	37	72.5
1	13	25.5
2	1	2
Clinical T stage2
T1	5	9.8
T2	12	23.5
T3	21	41.2
T4	2	3.9
Unknown	11	21.6
Clinical N stage2
N0	16	31.4
N1	19	37.3
N2	4	7.8
N3	2	3.9
Unknown	10	19.6

¹WHO: World Health Organization;

²TNM classification.